Mar 1 |
Insider Spends US$102k Buying More Shares In Beneficient
|
Feb 23 |
InMed Pharmaceuticals And 2 Other Penny Stocks Insiders Are Buying
|
Feb 15 |
Beneficient Third Quarter 2024 Earnings: US$1.98 loss per share (vs US$0.55 loss in 3Q 2023)
|
Feb 14 |
Beneficient (NASDAQ:BENF) Q3 2024 Earnings Call Transcript
|
Feb 14 |
Beneficient (BENF) Q3 2024 Earnings Call Transcript
|
Feb 13 |
Beneficient GAAP EPS of -$1.98, revenue of $10.24M
|
Feb 13 |
Beneficient Reports Results for Third Quarter Fiscal 2024
|
Jan 22 |
Beneficient Closes Initial Series of Liquidity Transaction Financings of Limited Partner Interests Sourced Through Preferred Liquidity Provider Program (“PLP Program”)
|